Purpose. Ampli® cation of genetic sequences on chromosome 12q13 is frequently found in soft tissue tumours. However, for the M DM 2 gene, over-expression of the M DM 2 protein has not always been shown to accompany gene ampli® cation, raising the possibility that ampli® cation of genetic sequences targets alternative genes on chrom osome 12q13 for over-expression. To investigate this discrepancy, we have examined 129 soft tissue tumours for ampli® cation of the M DM 2 gene using Southern analysis, and 39 of these tumours were also examined by immunohistochemical staining for M DM 2 over-expression. Results. Gene ampli® cation was identi® ed in 14/114 (12.3% ) of the malignant tumours, but was not identi® ed in any of the benign tumours; 21/39 (54% ) of the m alignant tumours also demonstrated MDM 2 over-expression. Within this group the M DM 2 gene was over-expressed in every tumour in which the gene ampli® cation was found, and over-expression in the absence of gene ampli® cation was also found in an additional 10 tumours. D iscussion. These data demonstrate a clear correlation between the presence of M DM 2 ampli® cation and M DM 2 over-expression, and provide persuasive evidence therefore that the ampli® cation of genetic sequences on chromosome 12q13 in soft tissue sarcomas targets the M DM 2 gene for over-expression. These data also indicate that alternative m echanisms may contribute to M DM 2 over-expression within some tumours.
Introduction
A variety of m am m alian tumour cells contain ampli® ed copies of genes whose transfo rm ing potential is then activated by their concom itant overexpression. In keeping w ith this, double m inute chrom osomes and hom ogeneously staining regions have been identi® ed in m alignant ® brous histiocytom as, liposarcom as, and alveolar and embryonal rhabdom yosarcom as. 1± 3 A cluster of genes which m ap to chrom osom e 12q13 have been found to be am pli® ed and over-expressed in soft tissue sarcom as, and include the M D M 2, GLI, C DK4, GA DD153 (C HO P) and SAS genes. 4± 8 The M D M 2 gene was originally identi® ed as a dom inantly transform ing oncogene am pli® ed and over-expressed from double minute chrom osom es in the 3T3D M cell line. 9 
M D M 2 was subsequently
show n to cooperate with RAS in the transfo rm ation of prim ary rat embryo ® broblasts, and to be ampli® ed in liposarcom as, m alignant ® brous histiocytomas (M FH s) and osteosarcomas. 4 
M D M 2 has
been show n to bind p53 and inhibit p53-m ediated transactivation 10 and is itself a target for p53-m ediated gene regulation via a cis-acting p53 response elem ent in its ® rst intron. 11 Elevated p53
expression results in increased levels of M DM 2 m RN A and protein, which in turn binds to and m odulates p53 function. It has now also been show n that M D M 2 can bind and inhibit the growth regulatory function of RB 1 12 and can activate E2F 1/D P1 to repress p53 function and to stim ulate the activity of S-phase prom oting transcription factors. 22 to a -32 P-labelled probes prepared using random oligonucleotide prim ers. 23 Filters w ere w ashed at 65°C to a ® nal stringency of 0.1 3 SSC, 0.1% SD S.
Am pli® cation of the M DM 2 gene was assesse d using a 1.5-kb M D M 2 probe prepared by PC R am pli® cation of reverse-transcribed normal ® broblast RN A using the follow ing prim ers: G G G AG C T CC T C G C C AC C A T G G T G A G G AG -C AGG CAAATG and GG GG TAC CC TCAT AG-AC AG G TCAAC TAGG G G. The PCR product was subcloned into the pBluescript vector and characterized by sequencing of its entire length. Following hyb ridization to the M D M 2 probe, blots were stripped by im m ersion in 0.1% SD S at 95°C and reprobed with pDCC 1.0 as a control to correct for differences betw een tum our sam ples in D N A loading and Southern transfer. 4 The DC C gene probe used was chosen as a control because allele loss at the D CC locus is found in only around 10% of soft tissue sarcom as, and hom ozygous deletion has not been demonstrated. 24 Allele loss without reduplication at the D CC locus in tum our D N A w ould result in a two-fold overestim ation of the degree of M DM 2 am pli® cation, and this error will be introduced in fewer than 10% of the tum ours exam ined. T he degree of am pli® cation was quanti® ed with a Joyce-Loebel Chrom oscan 3 scanning densitom eter, using absorbance at 530 nm . To allow for inaccuracies due to the effects of strom al contam ination, and for the non-linear response of the radiographic ® lm , only sam ples showing greater than ® ve-fold am pli® cation w ere considered to be am pli® ed. ® brosarcom a (STS49). T hese results are presented in Table 1 , and exam ples of M DM 2 gene ampli® cation are illustrated in F ig. 1. ST S162, a recurrence of the liposarcom a ST S44, was not included in the original group of tum ours but was subsequently analyzed, and also demonstrated M DM 2 gene am pli® cation.
Immunoh istochemical staining of tum our specimens for M DM 2 and p53 expression
Thirty-nine of the tum ours analyzed for M DM 2 am pli® cation w ere also exam ined for M D M 2 overexpression by im m unohistochem ical staining (Table  2 ). These tum ours were exam ined without knowledge of the M DM 2 gene am pli® cation results, but 
